This may be useful early on, but it gradually compromises macrophage function, driving the cells to stress, inflammation and death. At the later stages of disease (whether atherosclerosis or ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) revealed that insulin-like growth factor-binding ...

A study published in Nature Cardiovascular Research identifies an intrinsic anti-inflammatory factor that can be therapeutically targeted to reduce vascular inflammation and atherosclerosis.

Consequently, proinflammatory mediators have been identified that actively promote atherosclerosis ... IL-6 is a core component of inflammatory processes and the acute phase response, and ...

This research suggests that IGFBP6 responds to physical forces in blood vessels, helps reduce inflammation, and protects against artery-clogging diseases like atherosclerosis A study published in ...

Researchers from Fundación Jiménez Díaz and affiliated organizations have published data from a study that aimed to identify ...

Microplastics pose a threat to heart health, causing harmful changes in vascular cells and increasing the risk of cardiovascular diseases like atherosclerosis.